A Metabolic Rewiring in T Cells Points to New Immunopathology and Vaccine Strategies
A new study in the Proceedings of the National Academy of Sciences reveals a critical role for the nonoxidative pentose phosphate pathway (non-oxPPP) in regulating CD8+ T cell immunity. The research demonstrates that enzymes transketolase (TKT) and transaldolase (TALDO1) are essential for maintaining NADPH homeostasis, a key reducing agent that fuels the antioxidant defenses and biosynthetic demands of these immune cells. This metabolic pathway directly influences the functional capacity of CD8+ T cells, which are crucial for combating viral infections and cancer. The findings highlight a previously underappreciated link between core microbial metabolism and adaptive immunity, suggesting that targeting this pathway could modulate immune responses in various disease contexts.
Study Significance: For microbiologists and immunologists focused on host–microbe interactions and pathogenesis, this research provides a direct metabolic mechanism linking immune cell function to intracellular redox balance. Understanding how pathogens might exploit or disrupt this NADPH-dependent pathway could reveal new facets of microbial pathogenesis and immune evasion. This opens avenues for novel therapeutic strategies, including adjuvants for vaccine development that aim to bolster T cell metabolism or treatments for immunopathologies where T cell function is dysregulated.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
